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Inadequate uptake of testing for human immunodeﬁciency virus (HIV) remains a primary bottleneck toward
universal access to treatment and care, and is an obstacle to realizing the potential of new interventions for pre-
venting HIV infection, including treatment for prevention and preexposure prophylaxis. HIV self-testing
offers an approach to scaling up testing that could be high impact, low cost, conﬁdential, and empowering for
users. Although HIV self-testing was ﬁrst considered >20 years ago, it has not been widely implemented. We
conducted a review of policy and research on HIV self-testing, which indicates that policy is shifting toward a
more ﬂexible approach with less emphasis on pretest counseling and that HIV self-testing has been adopted in
a number of settings. Empirical research on self-testing is limited, resulting in a lack of an evidence base upon
which to base policy recommendations. Relevant research and investment in programs are urgently needed to
enable consideration of developing formalized self-testing programs.
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Access to testing for human immunodeﬁciency virus
(HIV) infection is a public health imperative. Effective
HIV prevention and care requires knowledge of one’s
HIV serostatus—deﬁned as having received a positive
result or a recent negative result. Yet access to and uptake
of HIV testing and counseling (HTC) remain inadequate,
and most people, including many at higher risk, do not
know their status [1]. Many people living with HIV, in-
cluding approximately 60% of those living in resource-
limited countries, are unaware of their HIV status [1].
This remains a signiﬁcant bottleneck toward universal
access to timely treatment and care; in addition, late
testing remains a major contributor to HIV-related mor-
tality in many countries [2, 3]. Inadequate knowledge of
HIV status will also compromise implementation of new
prevention strategies including male circumcision,
vaginal and rectal microbicides, oral preexposure prophy-
laxis (PrEP), and earlier/immediate antiretroviral therapy
(ART) for prevention. Optimizing HIV prevention, care,
and treatment in high-prevalence countries requires
regular testing by most adults [4]. This goal is far from
being realized under current HTC delivery strategies.
HIV self-testing is deﬁned as any form of HIV testing
in which an individual collects his or her own sample;
performs a simple, rapid laboratory test; and is, therefore,
the ﬁrst to know the results. Self-testing could add a new
approach to support scaling up testing with potential to
be high impact, low cost, conﬁdential, and empowering
for users. Sales of unregulated test kits and evidence of in-
formal self-testing by health workers indicate a demand
for self-testing [5, 6]. However, HIV self-testing, although
debated for >20 years, has not been widely endorsed [7].
HTC uptake will remain inadequate in resource-
poor settings, particularly among those at high risk,
without increasing HTC at the community level. The
availability of self-testing approaches could have a sig-
niﬁcant role in increasing access to testing. The aim of
this review was to examine current research and policy
priorities around HIV self-testing.
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METHODS
Publications related to self-testing were identiﬁed through sys-
tematically searching Embase, Medline, Popline, CAB abstracts,
and Global Health using the following search terms: (HIV OR
AIDS) AND (self-test* OR home test* OR home-based test*).
Gray literature was identiﬁed through a Google search of key
terms. References from relevant studies were examined for ad-
ditional citations, and experts and authors of pertinent studies
were contacted for any further references.
English-language references available through 21 May 2012
were included; no additional exclusion criteria were adopted,
and all references pertaining to self-testing were retained. Studies
were screened in 2 stages. In the ﬁrst stage, the ﬁrst reviewer read
the titles and abstracts of studies meeting the inclusion criteria.
In the second stage, the second reviewer evaluated the screening
criteria and reviewed the studies that had been selected, exclud-
ing any references not meeting the selection criteria. Disagree-
ments between reviewers were resolved through discussion. One
hundred twenty unique citations were identiﬁed, and 32 citations
representing 24 studies were retained in this review. Heteroge-
neity of populations, data collection methods, and outcomes
precluded meta-analysis of data, and results were analyzed quali-
tatively and reported in a summary table.
We identiﬁed key issues related to self-testing and results of a
review of related policy and research. We identiﬁed research
gaps and discussed applications for HIV self-testing among key
populations. We also considered the role of self-testing in sup-
porting increasing coverage of HIV prevention and care.
RESULTS
Arguments for and Against Self-Testing
Policymakers and local health authorities have reservations
about self-testing due to potential inaccuracy of results, psycho-
logical risks, and difﬁculty ensuring onward referral for positive
individuals [8–11] (Table 1). Proponents cite potential beneﬁts,
including increased knowledge of HIV status, facilitation of
repeat testing, earlier diagnosis, treatment and care, and de-
stigmatization through normalization of HIV testing [9–12]
(Table 1).
Early in the HIV epidemic, arguments against self-testing
carried more weight than now. Rapid tests can be highly sensi-
tive and speciﬁc [13]. Options such as oral ﬂuid tests can
achieve high accuracy, are less technically demanding than
blood-based tests, and eliminate sharps and biohazard disposal
problems—although a loss in sensitivity as compared to blood-
based testing has been documented [14]. As compared to earlier
in the epidemic, HIV knowledge is now more widespread, and
ART is increasingly available. However, the challenge of linking
testing and care remains a signiﬁcant concern [15].
HIV Testing Policy and Practice Environment
International policy no longer emphasizes individualized in-
depth pretest counseling, now recognized as a potential barrier
to HTC scale-up [16]. HTC policies continue to prioritize con-
ﬁdentiality, informed consent, and availability of counseling
[17]. Both individual and public health beneﬁts must be consid-
ered; new approaches must be convenient, ensure accurate test
results, have good linkages to prevention and care services, and
support wide and sustainable coverage, while still maintaining
informed consent, voluntarism, and conﬁdentiality. Human-
rights dialogue has also changed to emphasize the right to
access to HTC and treatment [18]. This shift has expanded the
range of HTC models in which self-testing could be an option.
International Policy Concerning Self-Testing for HIV
World Health Organization (WHO) policy emphasizes a public
health approach to HTC [17, 19], recognizing the importance
of knowledge of status and expansion of access to HTC. There
is support for pragmatic approaches to achieving higher cover-
age, such as routine facility-based provider-initiated testing and
counseling (PITC), in which pretest counseling may be mini-
mized. PITC is acceptable and increases access to HTC in many
settings [20].
Self-testing was ﬁrst mentioned by the Joint United Nations
Programme on HIV/AIDS/WHO in 2000, where countries were
cautioned to “strengthen quality assurance and safeguards on po-
tential abuse before licensing commercial HIV home collection
and home self-tests,” and it was recognized that “Home testing
and self-testing are likely to be more commonly used. This will
provide greater access (to voluntary counselling and testing
Table 1. Commonly Expressed Arguments Put Forth by Policy-
makers and Local Health Systems for and Against HIV Self-
Testing
Arguments for:
Potential for a dramatic increase in knowledge of HIV status
Increased confidentiality
Increased convenience
Autonomy and empowerment
Potential to remove the stigma surrounding HIV
Less resource intensive from the healthcare system perspective
Arguments against:
Greater potential for inaccurate results
Psychological danger when decoupling testing and counseling
Greater difficulty ensuring referral to treatment and care
Potential unethical use of HIV self-testing
Self-testing as justification for unprotected sex
Concern for safe disposal of biohazard material
Sources: [8–12].
Abbreviation: HIV, human immunodeficiency virus.
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[VCT]) for people who are reluctant to attend formal VCT ser-
vices. However, it is important that adequate information about
and provision of follow-up support services are available.” [21].
WHO included the potential beneﬁts and cautions self-testing in
its 2012 HTC framework, but did not give speciﬁc recommenda-
tions for use [22].
National HIV Self-Testing Policies
Recommendations for HTC in the United States, issued by
the US Centers for Disease Control and Prevention (CDC) in
2006 [23], aimed to minimize barriers to testing. The guidelines
address fear of stigmatization and support the integration of
HIV screening into routine healthcare services. Prevention
counseling at the time of testing was no longer recommended.
The US Food and Drug Administration (FDA) approved
home blood sample collection for HIV testing in 1996 [24]. Sale
of the over-the-counter (OTC) OraQuick in-home oral HIV test
was approved by the FDA in 2012, after unanimous recommen-
dation from the Blood Products Advisory Committee [25].
Some European countries had permitted sales of OTC tests
through pharmacies [26], but later legislation concerning diag-
nostic devices was standardized to cover most of the European
Union, and OTC test sales were halted.
The Kenyan National Guidelines for HTC (2009) [27] validate
the use of oral ﬂuid self-test kits and outline standards to support
this (Table 2). Kenya is the ﬁrst African country to develop guid-
ance concerning OTC HIV self-test kits for the general public.
Advocacy for Self-Testing
Many countries have advocated for self-testing. In 2008, the
United Kingdom’s National AIDS Trust called for more accessible
HIV testing and to permit and regulate self-testing, with
assessment of impact on risk-reduction behavior and access to
care [28]. The UK government now plans to license home HIV
test kits [29]. The Canadian Medical Association Journal issued a
statement supporting home testing [30]. A joint statement by the
Southern African HIV Clinicians Society argued that self-testing
presents an opportunity for scale-up of testing and that current
legal and policy frameworks be amended to include provisions for
self-testing and to remove restrictions on test kit distribution [31].
In a recent article, authors from the CDC highlighted the need
for strategies to strengthen implementation of HIV self-testing
[32]. The 2012 annual letter of the Bill and Melinda Gates Foun-
dation suggests that widespread HIV testing could be achieved
through use of an “inexpensive saliva test that can be used pri-
vately” [33].
HIV Self-Testing: A Review of Research Studies
Summary of Studies Included in This Review
The 32 citations identiﬁed by the search included 18 peer-
reviewed publications, 2 draft manuscripts, 5 reports, 6 abstracts,
and data from 1 online media source [7, 26, 34–63]. Citations
reported on a number of study populations, study designs, and
outcomes. These largely represented exploratory analyses and
sample sizes varied widely (range, N = 27 to N = 9169). Six
studies addressed health workers [8, 37, 39, 49, 50, 52]. Of the
non–health worker studies, 8 surveyed high-risk populations
and/or clients of HIV testing facilities to determine acceptability
of self-testing, preferred testing methods and reasons for prefer-
ences, and/or to identify attributes associated with acceptability
of HIV testing [40–42, 44, 45, 54, 55, 57–59, 61–63]. Seven studies
evaluated feasibility through participant self-testing, and 4 in-
cluded conﬁrmation of results (F Spielberg, S Camp, K Tapia,
unpublished data) [36, 38, 45, 50, 51, 53, 54, 56, 60, 64]. Two
studies considered the acceptability and feasibility of computer-
assisted self-testing [35, 47].We also identiﬁed 2 operational eval-
uations [26, 34]. Table 3 summarizes the research ﬁndings.
Table 2. Excerpt from the National Guidelines for HIV Testing
and Counselling in Kenya, 2009
The basic principle of self-testing has been used before for other
non-invasive tests, such as in pregnancy tests. Clients can access
test kits [for HIV] from pharmacies and other approved suppliers.
Self-testing is different from the traditional HTC strategies as the
client does not receive basic education, or pre-test counselling.
But in order to strengthen support systems for self-testing, there is
a need for basic standards. These standards include:
Test kits must be evaluated and approved for use in Kenya;
Test kits must be used before the expiry date;
Storage conditions must be adequate;
Test kits must pass quality control standards in Kenya;
Pharmacists must be trained and approved to dispense, counsel
and demonstrate the use of the test kit to clients and patients as
the need arises;
Follow-up and referral services, including confirming positive test
results, must be accessible for clients.
The vendor should be able to provide the client with step-by-step
instructions for
1. How to conduct the test;
2. How to correctly interpret the test results; and
3. Where to access follow-up and support services in the
surrounding area.
Persons must also be informed that the results are not confirmed
until a second, confirmatory test is conducted. This information
should also be made available on a package insert, to be included
on all HIV tests sold or distributed in Kenya, along with the
minimum standards mentioned above.
Pharmacists and other suppliers of self-test materials should
undergo HTC training and be certified by the Ministry of Health.
They must provide a private room for clients who may need further
information, counselling and social support. Utmost care should be
taken to avoid cases of misuse of test kits, as well as to prevent
negative social outcomes.
Source: Ministry of Public Health and Sanitation of Kenya [27].
Abbreviations: HIV, human immunodeficiency virus; HTC, HIV testing and
counseling.
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Table 3. Summary of Research Findings on HIV Self-Testing
Study Location
Study Design and
Population
Interested in Self-
Testing
Ever Informally Self-
Tested
Confirmation/
Disclosure
of Self-Test Results
Accuracy of
Self-Test Additional Comments
(A)Ministry of Health,
Kenya, 2006 [39]
N = 1897
Kenya Cross-sectional survey and
focus group discussions
among doctors, clinical
officers, pharmacists,
laboratory technologists,
and VCT counselors in all
8 provinces of Kenya
73% FGD indicate many
have self-tested.
64% of health workers
had ever tested for
HIV, but only 43%
had tested in the past
year and <50% of
partners had ever
tested.
(B) Corbett, 2007 [8]
N = 938
Ethiopia, Kenya,
Malawi,
Mozambique,
Zimbabwe
Situational analysis among
a range of disciplines
from front-line health
providers to support
service employees
79% 31% 85% disclosed to at
least 1 person,
46% sought
confirmatory
testing.
70% of health workers
had ever tested for
HIV. 31% had already
self-tested informally.
(C) Kalibala et al, 2011
[37] N = 161
Kenya Focus group discussions
and in-depth interviews
among doctors, clinical
officers, pharmacists,
laboratory technologists,
and VCT counselors
FGD indicate many
welcomed self-
testing.
FGD indicate already
common.
FGD indicate
disclosure is
important.
Many health workers
avoid conventional
testing services due
to fear of stigma, and
there would be a
great demand for
self-testing if made
available. Many
health workers have
already self-tested,
but expressed a need
for adequate
counseling and
referral services.
(D) Kruse et al, 2009
[48] N = 483
Zambia Cross-sectional survey,
focus group discussions
and in-depth interviews
among physicians,
clinical officers, nurses,
midwives, and pharmacy
staff
FGD indicate some
have self-tested.
(E) Skolnik et al, 2001
[44] N = 354
United States Cross-sectional survey
among clients at 2
stationary and 2 mobile
public HIV testing
facilities; 49%MSM
24% selected as
preferred method.
(F) Phillips et al, 2002,
2002, 2003 [40–42]
N = 2964
United States Cross-sectional state-
representative survey
37%would self-test.
R
eview
ofH
IV
Self-T
esting
•
C
ID
2013:57
(1
July)
•
129
Table 3 continued.
Study Location
Study Design and
Population
Interested in Self-
Testing
Ever Informally Self-
Tested
Confirmation/
Disclosure
of Self-Test Results
Accuracy of
Self-Test Additional Comments
(G) Spielberg et al,
2003 [45] N = 460
United States Cross-sectional survey
among at-risk
participants from a
needle exchange, 2
bathhouses, and 1 sex
venue for MSM, and an
STI clinic
20% selected as
preferred method.
(H) Lee et al, 2007 [38]
N = 350
Singapore Cross-sectional survey
among known HIV-
positive, and high-risk
individuals of unknown
status clients of 2 HIV
testing centers
89%would prefer self-
testing, 88% thought
self-testing should be
made available over-
the-counter.
Using Determine
finger-prick rapid
HIV test there
were 56% invalid
results.
89% of participants
preferred self-testing
but thought
confidential
counseling was
necessary.
(I) Spielberg et al, 2003,
2007 [46] N = 240
United States Evaluation of interest and
feasibility in self-testing
through 7 waves of self-
testing by HIV-positive
individuals, with
instructions for use
modified after feedback
form each wave
61%would have
preferred to test at
home.
Invalid and false-
negative results
were 9% and 5%
with finger-stick
and 6%with past-
generation oral
fluid, respectively.
( J) Gaydos et al, 2009,
2011 [36, 55] N = 565
United States Evaluation of acceptability
and accuracy of self-
testing by patients from
2 urban emergency
departments without HIV
diagnosis
85% agreed to self-test,
of those, 91% agreed
to oral self-testing
over blood-based.
Self-test results
99.6%
concordant with
health worker
using new-
generation oral
fluid test.
96% reported oral test
“not hard at all to
perform correctly,”
94% believed results
to be “definitely
correct,” 91%
trusted self-test
result, 98%would
recommend to a
friend.
(K) Project Masiluleke,
2009 [43]
South Africa Pilot research from a
nationwide program
among the general
population from
KwaZulu-Natal
Enthusiastic support
from both community
and healthcare
leaders
(L) Bui et al, 2010 [35] 3
FGD, 27 participants
United States Computer-assisted
counseling and rapid HIV
testing among staff from
chemical dependency
treatment centres
Staff thought their
clients would be
interested in
computer-assisted
counseling and in
self-testing, and
thought self-testing
would empower their
clients.
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Table 3 continued.
Study Location
Study Design and
Population
Interested in Self-
Testing
Ever Informally Self-
Tested
Confirmation/
Disclosure
of Self-Test Results
Accuracy of
Self-Test Additional Comments
(M) Spielberg, 2010 [47]
8 FGD of 4–8
participants
India Acceptability and feasibility
of computer-assisted
HIV self-testing among
Internet center staff and
potential participants
(single women, single
men, married women,
married men, couples)
Participants asked if
they wanted
computer counseling
and rapid self-testing
program in Internet
kiosks: on a scale of
1–10, the mean score
was 9.8 (mode 10);
86%would rather
test themselves than
have staff test them.
(N)MiraTes, 2008 [26]
N = 1112
Germany,
Netherlands,
United
Kingdom,
Belgium,
Austria,
Switzerland
Evaluation of motivation for
and experience with
home testing among a
general population of
people in Europe, aged
13–76 y (50% reporting
unprotected sex and
large proportion of MSM)
Only 67% of self-
testers reported they
would have had an
HIV test were a home
self-test unavailable.
98% reported they
would go to a
doctor if they
tested positive,
23% conducted
the self-test with
another person
present.
(O) Van Loon et al, 2007
[34] N = 40
Netherlands Annual report of
Checkpoint HIV testing
facility for the general
population
40/4400 opted for self-
testing, but only 1%
knew that self-testing
was an option prior to
arrival at facilities.
Of 40 clients, 13
returned to facility
within 1 mo, 16
returned 1–24 mo
later, 10 returned
>24 mo after self-
test.
(P) Kalibala et al, 2010
[49]; Kalibala,
personal
communication,
2011; N = 1454
Kenya Pilot study of feasibility and
acceptability of self-
testing among
healthcare workers at 7
hospitals
53% accepted self-test
kit, most tested
within a week.
The majority
preferred to
confirm results at
a VCT center,
though some
confirmed by self-
test.
Self-testing was found
to be acceptable and
convenient. Few
people used the
telephone hotline.
(Q) Chavula et al, 2010;
Choko et al, 2011;
[50, 52] N = 283
including 67 FGD
participants
Malawi Mixed quantitative and
qualitative study of
supervised self-testing
among residents in high-
density community
residents and peer group
members.
92% opted for self-
testing over standard
HIV testing and
counseling, 100%
would recommend
self-testing, 95%
“very likely” to self-
test in the future.
99.2% concordant
with health
worker using
new-generation
oral fluid test.
96% reported the test
was “not hard to do.”
Self-testing was
considered likely to
increase uptake and
frequency of HIV
testing.
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Table 3 continued.
Study Location
Study Design and
Population
Interested in Self-
Testing
Ever Informally Self-
Tested
Confirmation/
Disclosure
of Self-Test Results
Accuracy of
Self-Test Additional Comments
(R) Namakhoma et al,
2010 [51] N = 906
Malawi Mixed-methods study to
explore enablers and
barriers to HIV testing
among healthcare
workers at facilities in 2
districts of Malawi
11% Most would prefer to
test themselves than
have a “junior” test
them.
(S) Ronda et al, 2009;
Ickenroth et al, 2010;
Grispen et al, 2011
[57, 58, 62] N = 281
Netherlands Cross-sectional survey
among those who have
and have not taken a self-
test, to identify
determinants of self-
testing
19 HIV self-testers
had known
results: 1 HIV+
sought medical
consult; 18 HIV–:
72% no further
action, 16%
consulted with
family/friends,
11% changed
lifestyle, 6%
sought more
information.
HIV self-testing was
associated with
perceived
susceptibility,
perceived benefits,
self-efficacy,
experience of bodily
or environmental
event(s) that trigger
action, belief that
individuals or groups
support self-testing
(subjective norm)
(T) Sharma et al, 2011
[61] N = 6163
United States Cross-sectional survey
among MSM to describe
factors associated with
willingness to take a free
self-test
63% reported being
very likely and 20%
somewhat likely to
self-test.
The hypothetical offer
of incentives of $10,
$20, or $50
approximately
doubled reported
willingness to self-
test. Black MSM,
those having
unprotected anal sex
in past 12 mo, and
those unaware of
their HIV status were
more likely to be
willing to self-test.
(U) Estcourt et al, 2011;
Saunders et al, 2012
[54, 60] N = 411
United Kingdom Cross-sectional survey of
men 18–35 y to assess
acceptability of self-
testing for STI/HIV
91%would be willing to
self-test.
Primary care settings
(80%), sexual health
clinics (67%), and
pharmacies (65%)
were most
acceptable locations
for self-test kit
pickup.
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Table 3 continued.
Study Location
Study Design and
Population
Interested in Self-
Testing
Ever Informally Self-
Tested
Confirmation/
Disclosure
of Self-Test Results
Accuracy of
Self-Test Additional Comments
(V) Katz et al, 2012 [59]
N = 133
United States Qualitative study to
describe ease of use and
acceptability of oral HIV
self-testing among MSM
84% reported
availability of self-
testing would
increase frequency of
testing.
Of 69 online surveys
completed, 2
reported invalid
results and 1 was
incorrectly
performed.
46% reported they
would pay ≤$20 for
self-test, 26%would
pay $20–$40, 17%
would pay ≥$40.
11%would only use
if free. 86% expected
to test ≥4 times/year
if kits cost $5
compared to 26% if
kits cost $50.
(W) Carballo-Dieguez
et al, 2012 [53] N = 60
United States Mixed quantitative and
qualitative study to
determine whether HIV-
negative MSMwould
use self-testing as a
harm reduction strategy
to screen sexual partners
87% reported they
would likely self-test
if OTC testing
became available,
and 80%would likely
test a sexual partner
at home. 74% chose
to take the test in
front of an
interviewer.
Most participants
took the test
without mistake.
The most
commonmistake
was touching the
pad of the testing
wand with their
fingers.
Reported barriers to
testing with a partner
included being
impractical or killing
the mood, and when
under the influence
of alcohol/drugs;
although it was
thought some
partners might
refuse, a violent
reaction or
unmanageable
situation was not
anticipated from
bringing up self-
testing.
(X) Greacen et al, 2012
[56] N = 9169
France Cross-sectional survey
among MSM to assess
access and use of
unregulated self-test kits
available online
30%were aware of
online self-test kits.
Of those aware and
not already HIV-
positive, 3.5% had
accessed an
unregulated kit.
Of 3 men who
tested positive by
self-test, 2 had
sought
confirmatory
testing and 1
called an HIV
hotline.
Abbreviations: FGD, focus group discussion; HIV, human immunodeficiency virus; MSM, men who have sex with men; OTC, over-the-counter; STI, sexually transmitted infection; VCT, voluntary counseling and
testing.
R
eview
ofH
IV
Self-T
esting
•
C
ID
2013:57
(1
July)
•
133
Interest in and Acceptability of Self-Testing
Interest in HIV self-testing was high among all populations
surveyed. Among health workers from 5 African countries,
73%–79% reported interest in self-testing (studies A, B, P). In-
terest was highest among health workers who had never tested
for HIV (77% in study A). Respondents felt that self-testing
would reduceoreliminate stigmaaroundHIVtesting. Self-testing
was also viewed a supportive means for family members to test.
A large percentage of respondents had already self-tested in the
workplace.
In the United States, acceptability ranged from 83% to 89%
among respondents at a testing facility (study H), emergency de-
partment patients, and among men who have sex with men
(MSM; studies T, V, W) with 80% of MSM likely to test with
their sexual partner (study W). Among known HIV-positive par-
ticipants (study I), 61% would have preferred to self-test. In the
United Kingdom, 91% of men reported willingness to self-test
(study U), in 6 European countries (study N) 67% would not
have tested were a home test unavailable, and in the Netherlands
more than half of self-testers were ﬁrst-time testers (study O).
Among potential HIV testers in India (study M), 86% preferred
self-testing over clinic-based testing. In Malawi (study Q), 92% of
community members opted for supervised self-testing over stan-
dard voluntary HIV counseling and testing, with 100% indicating
they would recommend self-testing to a friend. Reasons for pre-
ferring self-testing across studies included privacy, autonomy,
conﬁdentiality and anonymity, convenience, and speed.
Accuracy of Self-Testing
Four studies evaluated accuracy of self-testing, of which 2
( studies J, Q) used the current-generation oral ﬂuid tests. They
found 99.6% and 99.2% concordance between results of partic-
ipants and trained healthcare professionals, respectively. The
poor performance results for ﬁnger-prick testing (studies H, I)
were based on earlier versions of rapid tests. Though one (study I)
was an older generation CLIA-waived test, the second (study H)
required 14 steps. These results may not be applicable to current
versions of rapid, whole blood tests which now involve fewer
steps. Decreased sensitivity in oral tests compared to blood
based tests has been reported [14] but there are limited avail-
able data on the performance of whole blood tests in the context
of self-testing.
Acceptability and Evidence of Harm
Self-testing de-links testing and counseling, potentially depriv-
ing individuals of linkage to a range of critical services. Focus
group discussions raised concerns about user error, lack of
counseling, and coping capacity for positive results. The
minimal data that were available showed little evidence of
harm, including expressing regret, feeling unprepared for the
results, and anecdotal evidence of fear of self-testing (similar
fears were also expressed with other testing methods). These
descriptive studies offer no comparisons with people who
tested through standard HTC services.
Self-reported results disclosure and/or conﬁrmatory testing ap-
peared high overall. The majority of health workers reported that
their self-test was not their last HIV test, implying that they had
sought conﬁrmation. In a general population of self-testing
clients (study N), 98% reported they would go to a doctor if they
tested positive, and 23% had self-tested with another person
present. In study O, 98% of self-testing clients returned for
another HIV test. In Malawi (study Q), 95% of self-testers report-
ed they would self-test again. Among Europeans in study N, 62%
reported that they would avoid risk following self-testing, 37%
reported having always been careful and would continue to do so,
and 1% reported they would not avoid risk after self-testing.
DISCUSSION
Summary of Research
This review suggests that self-testing may be an additional way
to meet the need for conﬁdential and accessible HIV testing,
and may discourage current unregulated self-testing. Current
global and national policies on HTC give less emphasis on the
need for pretest counseling. Advocacy for self-testing is becom-
ing more common, and some national policies now support
regulated self-testing.
Interest and acceptability of self-testing was high in studies
reviewed, including among key populations surveyed. Introduc-
tion of self-testing programs could, therefore, increase demand
for and uptake of HIV testing. The choice of assay will be criti-
cal to support accuracy of results. The limited available data
suggest that oral ﬂuid testing may have lower sensitivity and
speciﬁcity than other point-of-care HIV testing, and informa-
tion about self-testing should therefore emphasize that the
self-test result should be considered a screening rather than a
deﬁnitive test. Self-tests should be conﬁrmed by self-referral to
other HTC services. None of the studies reviewed addressed the
issue that conﬁrmation of results, according to nationally agreed
algorithms, must be ensured. Data are presently insufﬁcient to
assess whether self-testing leads to timely linkage to care.
Limitations
Only 24 descriptive studies contained HIV self-testing informa-
tion, many with small sample sizes. Study populations were
heterogeneous, as were study designs, data collection methods,
and outcomes, making comparability across studies difﬁcult and
generalizability of ﬁndings limited. Overall, the studies included
in this review were largely exploratory and methodological
quality was low. Just 2 studies evaluated the accuracy of self-
testing using current oral ﬂuid tests. Only 1 study explored evi-
dence of harm; others examined concerns about implementation
134 • CID 2013:57 (1 July) • Napierala Mavedzenge et al
of self-testing. All but 2 studies were cross-sectional and do not
provide an indication of possible risks or beneﬁts of self-testing
in the longer term.
Research Gaps and Recommendations
Although studies indicate interest in self-testing, optimal
service delivery strategies have not been documented or
Table 4. Identiﬁed Gaps in Research on HIV Self-Testing
Gaps Comments Recommendations
1 Effect of self-testing on
levels of uptake of first,
repeat, and recent HIV
testing
Evidence from studies frommany countries that
self-testing is highly acceptable. Evidence that
there are already high levels of self-testing in
African health workers. Unregulated self-test kits
are widely available on the Internet, indicating a
market for self-testing. Current indications
suggest self-testing may be mainly used for the
first test, and then by frequent repeaters.
Evaluation of uptake of ever-testing and recent
testing should be assessed before
implementation of self-testing programs and then
monitored at workforce level.
Methods to promote regular repeat testing an
important issue to be explored in operational
research.
2 Secondary beneficial
effects of self-testing
Potential for personal empowerment, diminished
HIV stigma associated with knowing one’s status
needs evaluation.
Qualitative research in representative and pilot sites
would allow this to be assessed.
3 Secondary harmful effects
of self-testing
Potential for greater psychological trauma
compared to counselor-provided testing, and
greater likelihood of inaccurate results from user
error needs evaluation and failure to confirm
result.
System for reporting serious adverse outcomes
should be considered in representative or pilot
sites.
4 Couples testing There are currently no data on the acceptability and
impact of couples self-testing. Ongoing study in
Kenyan Health Workers considers this.
Operational research on couples self-testing is need
to explore this potential approach.
5 Training, information, and
counseling needed to
ensure accuracy and
minimize potential harm
Defining the essential components and how to
provide them in ways that are effective but do not
represent a disincentive will be an important part
of operationalizing self-testing programs.
In practice will vary according to distribution
strategy and population.
6 Quality assurance Some studies have demonstrated a lower
sensitivity with oral HIV testing as compared to
blood-based testing. Current approach
recommends confirmatory testing, but the
acceptability of this and need for confirmation of
negative results is not known.
Finger prick–based self-testing may be a
consideration for future research. Current
recommendations regarding confirmation of
results should remain in place. Confirmation for
repeat tests with no change in result may be less
imperative.
7 Entry into HIV prevention/
care services
Only assessed in participants in the USA Home
Access service: qualitative research suggests
high ability/willingness to accept results and seek
entry into care once positive status is known.
Other studies suggest that entry into care is
lower with community-based testing as
compared to clinic-based testing. Some reasons
for this may be compounded with home self-
testing.
Self-referral into prevention and/or care services
should be promoted, with confirmatory testing at
this point. Additional data are required to inform
linkage to care, and how best to promote this
within the context of self-testing.
8 Cost-effectiveness Important to determine relative to other options
once models are established.
Costs and cost-effectiveness studies are required.
9 Effect of cost on demand Few data exist to determine acceptable costs for
test kits, including for populations at highest risk,
and who are unlikely to test through current
testing strategies.
The most acceptable price or price rangewill vary
by country and by populations within a given
country. Topic for research
10 Marketing and distribution
of self-testing
No data on what marketing or distribution strategies
will attract populations at highest risk, and those
who are unlikely to test through current testing
strategies.
Topic for research
11 Systems for monitoring
and tracking self-testing
Few data exist on optimal monitoring systems by
which we can track who received a test, got
results, made the linkage to prevention or care
services, etc. Unique challenges for monitoring
recruitment and retention at each step in the
testing and treatment cascade for those testing
without initial contact with a health provider.
The use of mHealth technologies should be
explored to track self-testing and linkage to care.
Abbreviation: HIV, human immunodeficiency virus.
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published (Table 4). Data on disclosure, accuracy, conﬁrma-
tion, and risks associated with self-testing are limited, and more
information is needed on the training, education, and counsel-
ing needed to minimize potential harm. The potential risks of
self-testing have not yet been explored in depth. Rates of
linkage to a range of prevention, treatment, and care services
are unavailable. Information on the potential for secondary
beneﬁts of self-testing is unavailable, and the impact of formal-
ized self-testing on informal practices is unclear. There are also
insufﬁcient data on how best to market and distribute self-test
kits to reach those at highest risk, what effect the cost of self-
test kits will have on demand, and how cost-effective self-
testing will actually be.
Considerations for Self-Testing Programs and Potential
Applications
Healthcare Workers
In generalized epidemics, the provision of formalized self-
testing for healthcare workers is potentially appropriate and
acceptable. There are already high rates of informal self-testing,
as well as familiarity with and access to HIV prevention and
care [64]. Obstacles to accessing HIV testing (eg, workplace
gossip, stigma, discrimination) should be assessed and ad-
dressed, and conﬁdentiality and access to follow-up services
ensured. In Kenya, self-testing for healthcare workers is being
implemented, with oral test kits available to take home for
healthcare workers and their partners.
Couples
Knowledge of partner HIV status is low, and a signiﬁcant pro-
portion of transmission occurs within stable serodiscordant
couples [65]. Couples testing can increase safer sexual behavior
and allow timely uptake of and support for ART. Self-testing
could provide conﬁdentiality, autonomy, and convenience, and
be a potentially suitable model for couples. However the use of
self-testing for “serosorting” presents practical and program-
matic problems, if the sensitivity of self-testing is suboptimal
and because acute infection may not be detected [66]. There are
also potential social issues and challenges for clinical follow-up
with partner self-testing. Although there are no data regarding
coercion, coercive testing by partners is a potential concern,
and rigorous monitoring for adverse events is critical if this ap-
proach is to be considered.
MSM and Injecting Drug Users
In many countries, HIV transmission remains high among
MSM and injecting drug users, and lack of awareness of HIV
status is a key factor driving transmission rates [67, 68]. Reluc-
tance to test has been associated with fear of results, and stigma
and discrimination often hinder utilization of HIV services [69, 70].
Underserved by many HTC approaches, MSM and injecting
drug user populations may beneﬁt from self-testing approaches.
ART for Prevention and Other ART-Based Prevention
Strategies
There has been recent debate around “treatment as prevention”
[71, 72] and other promising approaches such as microbicides
and oral PrEP, all of which require knowledge of HIV status.
Successful implementation of these approaches requires near-
universal, regular HIV testing. For example, PrEP requires
regular (currently monthly) repeat testing, which is often in-
convenient [73, 74]. Self-testing options may facilitate this.
CONCLUSIONS, CHALLENGES, CONSTRAINTS,
AND THEWAY FORWARD
It is important to scale up HTC to meet global and national
prevention and treatment goals, and to support new prevention
tools as they become available. Globally, progress has been
made toward universal HTC, however many people with HIV
remain undiagnosed. There is demand for HIV self-testing and
evidence that unregulated self-testing is being practiced. Self-
testing could enable people reluctant to test or retest through
existing approaches, to learn their status and beneﬁt from treat-
ment and prevention. For effective self-testing, monitoring for
quality assurance, conﬁrmation of test results, and appropriate
and acceptable links to counseling, care, treatment, and preven-
tion are essential. High uptake will require active promotion
and community-level distribution of test kits. Recent global
policy has moved toward simplifying HTC, resulting in a more
routine approach to testing without requirements for lengthy
pretest counseling. As oral ﬂuid HIV tests become more widely
available, there is a need to explore self-testing by assessing ap-
proaches that provide safe environments that link self-testing to
other HIV services and carefully monitoring and evaluating
these approaches to provide evidence for larger-scale imple-
mentation.
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